What is the first treatment for acute lymphoblastic leukaemia?

Acute lymphoblastic leukaemia, or ALL, affects immature blood cells in the bone marrow. Initial chemotherapy is designed to reduce leukaemia cells throughout the body and restore healthy blood-cell production. Treatment commonly has an initial phase followed by further phases that consolidate the response and protect against disease in areas such as the brain and spinal fluid. Medicines may be given through a vein, by mouth, or into the fluid around the spinal cord.

The plan is adapted to the ALL subtype, laboratory findings, age, general health, and early response. Some people later need an allogeneic stem cell transplant or CAR T-cell therapy, particularly when the disease does not respond adequately or returns. Those treatments are not automatically the first step for everyone.

Attend blood tests and treatment appointments as scheduled, and follow instructions about infection precautions and medicines. Report fever, chills, mouth sores, diarrhoea, unusual bruising, or bleeding promptly. Keep an updated list of every medicine, including supplements. Ask for help with transport, food, and daily care if treatment leaves you weak, because low blood counts and treatment effects can change quickly.

Call the haematology team urgently for fever, shaking chills, new breathlessness, chest pain, confusion, persistent vomiting, or bleeding. Go to emergency care for severe breathing difficulty, collapse, or uncontrolled bleeding. During intensive treatment, infection can become dangerous quickly even when symptoms first seem mild; use the emergency instructions supplied by your treatment centre.

Which ALL subtype do I have, and what is the aim of each treatment phase? How will you monitor response and blood counts? Will treatment include spinal-fluid medicine? What symptoms require an immediate call? Under what circumstances might cellular therapy or a stem cell transplant be considered?